S. Mallard

Results of triple therapy with interferon‐alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in early chronic phase

M. Andreeff, H. Kantarjian, G. Garcia-Manero, 2003, Cancer.

Intravenous Corticosteroids to Reduce Gemtuzumab Ozogamicin Infusion Reactions

E. Estey, J. Cortes, F. Giles, 2003, The Annals of pharmacotherapy.

Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia.

B. Cheson, H. Kantarjian, J. Cortes, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simultaneous homoharringtonine and interferon‐α in the treatment of patients with chronic‐phase chronic myelogenous leukemia

M. Andreeff, H. Kantarjian, G. Garcia-Manero, 2002, Cancer.